CLINICAL_TRIALS
trial_result
· 2022-07-06
Clinical Trial Update: Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel [Phase 3]
Summary
Phase 3 trial assessing long-term safety of once-daily omiganan topical gel for rosacea has completed with results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Maruho Co., Ltd. | Conditions: Rosacea | Phase 3 | Status: COMPLETED | Results posted: 2022-07-06